Magnetar Financial LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Magnetar Financial LLC

  • $3.44 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$26.2 - $36.08 $249,895 - $344,131
9,538 New
9,538 $256,000
Q1 2022

May 16, 2022
SELL
$39.62 - $69.97 $155,944 - $275,401
-3,936 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$58.09 - $82.51 $228,642 - $324,759
3,936 New
3,936 $261,000
Q2 2020

Aug 14, 2020
SELL
$26.12 - $43.27 $269,950 - $447,195
-10,335 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$20.56 - $63.12 $212,487 - $652,345
10,335 New
10,335 $297,000

Others Institutions Holding ARWR

# of Institutions
294
Shares Held
90.8M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.07B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email